Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCI | P41743 | 1/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.57 |
| ▸ | MAPT | P10636 | 3/20 | 0.57 |
| ▸ | RAD52 | P43351 | 1/20 | 0.57 |
| ▸ | PARP1 | P09874 | 1/20 | 0.56 |
| ▸ | QPCT | Q16769 | 3/20 | 0.54 |
| ▸ | QPCTL | Q9NXS2 | 2/20 | 0.54 |
| ▸ | MMP12 | P39900 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | NAMPT | P43490 | 1/20 | 0.52 |
| ▸ | XDH | P47989 | 1/20 | 0.52 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30024579 | 1.00 | PRKCI (0.59) | PRKCIKDM4EMAPTRAD52PARP1 | |
| SCHEMBL352025 | 0.83 | LMNA (0.55) | PRKCIKDM4EMAPTRAD52PARP1 | |
| SCHEMBL29265408 | 0.80 | KDM4E (0.60) | PRKCIKDM4EMAPTRAD52PARP1 | |
| SCHEMBL29265407 | 0.80 | KDM4E (0.60) | PRKCIKDM4EMAPTRAD52PARP1 | |
| SCHEMBL8634290 | 0.77 | QPCT (0.68) | PRKCIKDM4EMAPTRAD52QPCT | |
| Phloroglucinol SCHEMBL18816738 | 0.75 | QPCT (0.51) | PRKCIKDM4EMAPTRAD52PARP1 | |
| SCHEMBL8519991 | 0.74 | PRKCI (0.59) | PRKCIKDM4EMAPTRAD52QPCT | |
| SCHEMBL4740277 | 0.74 | PRKCI (0.59) | PRKCIKDM4EMAPTRAD52PARP1 | |
| SCHEMBL3724998 | 0.74 | PRKCI (0.59) | PRKCIKDM4EMAPTRAD52QPCT | |
| SCHEMBL1286648 | 0.74 | PRKCI (0.59) | PRKCIKDM4EMAPTRAD52QPCT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 247 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12246291-B2 | Metal organic framework glass membrane and preparation method thereof | NINGBO UNIVERSITY (CN) | 2025-03-11 | — | — | US | claimed |
| CN-119534689-A | High-sensitivity quantitative and structural identification method of cobalamin and application thereof | 中国科学院沈阳应用生态研究所 | 2025-02-28 | — | — | CN | claimed |
| CN-117899624-A | Metal-organic framework glass gas separation membrane and preparation method and application thereof | 宁波大学 | 2024-04-19 | — | — | CN | claimed |
| EP-3386511-B2 | METHODS FOR TREATING HUNTINGTON'S DISEASE | PTC THERAPEUTICS INC (US) | 2024-03-20 | — | — | EP | claimed |
| WO-2023244996-A2 | HETEROCYCLIC AND HETEROARYL COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE | PTC THERAPEUTICS, INC. (US) | 2023-12-21 | — | — | WO | claimed |
| US-20220331745-A1 | METAL ORGANIC FRAMEWORK GLASS MEMBRANE AND PREPARATION METHOD THEREOF | NINGBO UNIVERSITY (CN) | 2022-10-20 | — | — | US | claimed |
| CN-110975648-B | Metal organic framework glass film and preparation method thereof | 宁波大学 | 2021-08-20 | — | — | CN | claimed |
| EP-3814357-A1 | HETEROCYCLIC AND HETEROARYL COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE | PTC Therapeutics, Inc. (US) | 2021-05-05 | — | — | EP | claimed |
| CN-107382984-B | Preparation method of medicine for treating leukemia | 扬州市三药制药有限公司 | 2020-07-10 | — | — | CN | claimed |
| CN-110975648-A | Metal organic framework glass film and preparation method thereof | 宁波大学 | 2020-04-10 | — | — | CN | claimed |
| EP-0700295-A4 | VITAMIN B 12? MEDIATED ORAL DELIVERY SYSTEMS FOR GCSF AND EPO | BIOTECH AUSTRALIA PTY LTD (AU) | 1998-09-30 | — | — | EP | claimed |
| EP-0701448-A4 | AMPLIFICATION OF THE VITAMIN B 12? UPTAKE SYSTEM USING POLYMERS | BIOTECH AUSTRALIA PTY LTD (AU) | 1997-01-02 | — | — | EP | claimed |
| US-5548064-A | COLONY STIMULATING FACTOR; ORAL ADMINISTERING | BIOTECH AUSTRALIA PTY LIMITED (AU) | 1996-08-20 | — | — | US | claimed |
| CN-1126441-A | Amplification of vitamin B12 absorption System Using polymers | BIOTECH AUSTRALIA PTY LTD (AU) | 1996-07-10 | — | — | CN | claimed |
| CN-1126436-A | Vitamin B12 mediated oral delivery systems for GCSF and EPO | BIOTECH AUSTRALIA PTY LTD (AU) | 1996-07-10 | — | — | CN | claimed |
| EP-0701448-A1 | AMPLIFICATION OF THE VITAMIN B 12? UPTAKE SYSTEM USING POLYMERS | BIOTECH AUSTRALIA PTY. LIMITED (AU) | 1996-03-20 | — | — | EP | claimed |
| EP-0700295-A1 | VITAMIN B 12? MEDIATED ORAL DELIVERY SYSTEMS FOR GCSF AND EPO | BIOTECH AUSTRALIA PTY. LIMITED (AU) | 1996-03-13 | — | — | EP | claimed |
| US-5449720-A | Amplification of the VB12 uptake system using polymers | BIOTECH AUSTRALIA PTY LIMITED (AU) | 1995-09-12 | — | — | US | claimed |
| WO-1994027641-A1 | AMPLIFICATION OF THE VITAMIN B12 UPTAKE SYSTEM USING POLYMERS | BIOTECH AUSTRALIA PTY. LIMITED (AU) | 1994-12-08 | — | — | WO | claimed |
| WO-1994027613-A1 | VITAMIN B12 MEDIATED ORAL DELIVERY SYSTEMS FOR GCSF AND EPO | BIOTECH AUSTRALIA PTY. LIMITED (AU) | 1994-12-08 | — | — | WO | claimed |